Review: taking Methadose and Quetiapine fumarate together


Summary

Drug interactions are reported among people who take Methadose and Quetiapine fumarate together. This review analyzes the effectiveness and drug interactions between Methadose and Quetiapine fumarate. It is created by eHealthMe based on reports of 1,270 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Methadose and Quetiapine fumarate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Methadose

Methadose has active ingredients of methadone hydrochloride. It is often used in drug abuse. (latest outcomes from Methadose 2,934 users)

Quetiapine Fumarate

Quetiapine fumarate has active ingredients of quetiapine fumarate. It is often used in bipolar disorder. (latest outcomes from Quetiapine fumarate 5,611 users)

On Aug, 23, 2016

1,270 people who take Methadose, Quetiapine Fumarate are studied.


Number of reports submitted per year:

Methadose and Quetiapine fumarate drug interactions.

Drug effectiveness over time:

Methadose:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (3 of 6 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 57.0% - (4 of 7 people)
  • 2 - 5 years: 50.0% - (5 of 10 people)
  • 5 - 10 years: 50.0% - (2 of 4 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 1 people)
Quetiapine Fumarate:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 9 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 33.0% - (1 of 3 people)
  • 2 - 5 years: 20.0% - (2 of 10 people)
  • 5 - 10 years: 66.0% - (2 of 3 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Methadose:
  • female: 52.0% - (11 of 21 people)
  • male: 44.0% - (4 of 9 people)
Quetiapine Fumarate:
  • female: 13.0% - (3 of 22 people)
  • male: 33.0% - (3 of 9 people)

Drug effectiveness by age:

Methadose:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 55.0% - (5 of 9 people)
  • 30-39: 42.0% - (3 of 7 people)
  • 40-49: 55.0% - (5 of 9 people)
  • 50-59: 66.0% - (2 of 3 people)
  • 60+: 0.0% - (0 of 2 people)
Quetiapine Fumarate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 22.0% - (2 of 9 people)
  • 30-39: 14.0% - (1 of 7 people)
  • 40-49: 18.0% - (2 of 11 people)
  • 50-59: 33.0% - (1 of 3 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • delirium
  • myoclonus
  • urethral cancer
  • sedation
  • electrocardiogram qt prolonged
  • completed suicide
  • suicide attempt
  • disorientation
  • blood potassium increased
  • confusional state
1 - 6 months:
  • diabetes mellitus
  • vomiting
  • type 2 diabetes mellitus
  • hyperlipidaemia
  • hypercholesterolaemia
  • nausea
  • pancreatitis
  • hyperglycaemia
  • pneumonia
  • blood creatinine increased
6 - 12 months:
  • diabetes mellitus
  • hyperglycaemia
  • neuropathy peripheral
  • dementia
  • fear
  • hallucination
  • major depression
  • paranoid personality disorder
  • type 2 diabetes mellitus
  • diabetic neuropathy
1 - 2 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • pancreatitis
  • hyperglycaemia
  • diabetic neuropathy
  • pneumonia
  • hyperlipidaemia
  • pancreatitis acute
  • hypercholesterolaemia
  • pyrexia
2 - 5 years:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • pancreatitis
  • blood cholesterol increased
  • hyperglycaemia
  • diabetes mellitus inadequate control
  • chest pain
  • neuropathy peripheral
  • diabetic neuropathy
  • back pain
5 - 10 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • blood cholesterol increased
  • pancreatitis
  • obesity
  • muscle spasms
  • chest pain
  • convulsion
  • depression
  • gallbladder disorder
10+ years:
  • pancreatitis
  • anxiety disorder
  • back pain
  • bone pain
  • gastroenteritis
  • panic disorder
  • schizoaffective disorder
  • sleepiness - during the day
  • suicide attempt
  • type 2 diabetes mellitus
not specified:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • insomnia
  • pancreatitis
  • depression
  • completed suicide
  • anxiety
  • vomiting
  • cardiac arrest
  • weight increased

Most common drug interactions by gender *:

female:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • pancreatitis
  • insomnia
  • blood cholesterol increased
  • neuropathy peripheral
  • anxiety
  • back pain
  • depression
  • hyperglycaemia
male:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • pancreatitis
  • vomiting
  • hyperglycaemia
  • insomnia
  • cardiac arrest
  • nausea
  • pneumonia
  • pyrexia

Most common drug interactions by age *:

0-1:
  • pancreatitis
  • diabetes mellitus
  • tardive dyskinesia
  • atrial septal defect
  • back pain
  • blindness
  • blood triglycerides increased
  • diabetes mellitus inadequate control
  • diabetes mellitus non-insulin-dependent
  • diabetic coma
10-19:
  • sleep apnoea syndrome
  • brain oedema
  • unresponsive to stimuli
  • depression
  • alopecia
  • drug toxicity
  • renal failure
  • dyspnoea
  • hypoxia
  • metabolic alkalosis
20-29:
  • cardiac arrest
  • completed suicide
  • respiratory arrest
  • overdose
  • cardio-respiratory arrest
  • dizziness
  • dyspnoea
  • fatigue
  • vomiting
  • sleep disorder
30-39:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • pancreatitis
  • completed suicide
  • blood cholesterol increased
  • convulsion
  • diabetic neuropathy
  • cardiac arrest
  • anxiety
  • electrocardiogram qt prolonged
40-49:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • pancreatitis
  • hyperglycaemia
  • pancreatitis acute
  • nausea
  • back pain
  • insomnia
  • dementia
  • neuropathy peripheral
50-59:
  • diabetes mellitus
  • insomnia
  • depression
  • type 2 diabetes mellitus
  • anxiety
  • vomiting
  • decreased appetite
  • diabetic neuropathy
  • muscle spasms
  • neuropathy peripheral
60+:
  • type 2 diabetes mellitus
  • pancreatitis
  • diabetes mellitus
  • fall
  • cardiac arrest
  • respiratory arrest
  • cardiac failure congestive
  • completed suicide
  • death
  • fatigue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Methadose and Quetiapine fumarate?

Can you answer these questions?

More questions for: Methadose, Quetiapine fumarate

You may be interested in these reviews

More reviews for: Methadose, Quetiapine fumarate

On eHealthMe, Methadose (methadone hydrochloride) is often used to treat drug abuse. Quetiapine fumarate (quetiapine fumarate) is often used to treat bipolar disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.